Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03470805
What this trial is testing

Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma

Who this might be right for
Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario 9
Testing effectiveness (Phase 2)Study completedNCT01367288
What this trial is testing

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Who this might be right for
Locally Advanced Breast CancerDuctal Histologic TypeWithout Her 2 Overexpression
Hospices Civils de Lyon 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656
What this trial is testing

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Who this might be right for
EdemaErythemaEstrogen Receptor Negative+6 more
M.D. Anderson Cancer Center 71
Large-scale testing (Phase 3)UnknownNCT02738346
What this trial is testing

SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013

Who this might be right for
Small Cell Lung Cancer
University Hospital, Angers 164
Not applicableUnknownNCT03316469
What this trial is testing

Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS

Who this might be right for
Polycystic Ovary Syndrome
Ain Shams University 40
Not applicableStudy completedNCT06777290
What this trial is testing

Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Charles University, Czech Republic 14
Not applicableLooking for participantsNCT06682442
What this trial is testing

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaStage III Nasopharyngeal Carcinoma AJCC v8Stage IVA Nasopharyngeal Carcinoma AJCC v8+2 more
University of California, San Francisco 66
Not applicableUnknownNCT05301790
What this trial is testing

Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy

Who this might be right for
Role of MRI in Evaluation of Breast Cancer
Assiut University 45
Post-approval studies (Phase 4)Study completedNCT02316327
What this trial is testing

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Fundacion Clinic per a la Recerca Biomédica 19
Not applicableEnded earlyNCT04581070
What this trial is testing

The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic"

Who this might be right for
CancerCOVID-19
Cancer Trials Ireland 4
Not applicableEnded earlyNCT00896961
What this trial is testing

EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer

Who this might be right for
Stage I Adult Soft Tissue SarcomaStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage II Adult Soft Tissue Sarcoma+3 more
National Cancer Institute (NCI) 120
Early research (Phase 1)Looking for participantsNCT07733505
What this trial is testing

Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?

Who this might be right for
Ovarian Cancer
Odense University Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT02495103
What this trial is testing

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaHereditary LeiomyomatosisRenal Cell Cancer
National Cancer Institute (NCI) 7
Large-scale testing (Phase 3)Active Not RecruitingNCT04884360
What this trial is testing

D9319C00001- 1L OC Mono Global RCT

Who this might be right for
Ovarian Cancer
AstraZeneca 366
Large-scale testing (Phase 3)Study completedNCT04137627
What this trial is testing

Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjuvant Chemotherapy
Universitas Indonesia 50
Testing effectiveness (Phase 2)Study completedNCT00690703
What this trial is testing

Radiofrequency Ablation of Pulmonary Tumors Response Evaluation

Who this might be right for
Non Small Cell Lung CancerPulmonary Metastases
Angiodynamics, Inc. 106
Testing effectiveness (Phase 2)Looking for participantsNCT05628922
What this trial is testing

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Who this might be right for
Nasopharyngeal Cancer
Fudan University 198
Testing effectiveness (Phase 2)Study completedNCT02083354
What this trial is testing

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Who this might be right for
CancerMelanoma
Novartis Pharmaceuticals 77
Not applicableEnded earlyNCT03738553
What this trial is testing

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

Who this might be right for
HER2-positive Breast Cancer
University of Washington 13
Not applicableActive Not RecruitingNCT04994795
What this trial is testing

Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sophia Genetics SAS 4,000
Next Page